Influence of Latent Miofascial Trigger Points in the Vertical Jump in Female Voleyball Players

Sports Physical Therapy Clinical Trial

— LMTP_Volley  

Official title:

Influence of Latent Miofascial Trigger Points in the Vertical Jump in Female Voleyball Players

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05058625
• Other study ID #: Sánchez-Sierra1
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 15, 2021
• Est. completion date: January 15, 2022

Study information

• Verified date: September 2021
• Source: University of Castilla-La Mancha
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the effects of dry needling of latent myofascial trigger points on vertical jump height in female volleyball players

Description:

Evaluate a sample of female volleyball players after using dry needling on latent myofascial trigger points and verify if it would have an improvement of the vertical jump

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: January 15, 2022
• Est. primary completion date: January 15, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthy female volleyball players

• No Lower limbs injuries in the last 6 months

• Presence of latent trigger points in gastrocnemius

• Familiar with performing CMJ test

Exclusion Criteria:

• Active trigger points in the lower limbs

• Any contraindication of usind dry needling

• Any pathology that prevented the performance of CMJ test

Related Conditions & MeSH terms

• Sports Physical Therapy

Intervention

Device:
• Dry Needling plus normal volleyball training
Once the trigger point has been identified, we will use the Hong tecnique looking for a local spasm response

Other:
• Control Group
Normal volleyball training

Locations

Country	Name	City	State
Spain	Alberto Sánchez Sierra	Toledo

Sponsors (1)

Lead Sponsor	Collaborator
University of Castilla-La Mancha

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	pre-intervention
Primary	Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	Immediately post-intervention
Primary	Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	72 hours post-intervention
Primary	Vertical Jump	Vertical jump will be measured CMJ test using the app My Jump 2	one week post-intervention